| [1] | 
																						 
											  Ali R, Nagalli S. Hyperammonemia[M]. StatPearls: Treasure Island(FL), 2022.
											 											 | 
										
																													
																						| [2] | 
																						 
											 中国医师协会医学遗传医师分会临床生化专业委员会, 中华医学会儿科学分会内分泌遗传代谢学组, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组. 中国尿素循环障碍诊断治疗和管理指南[J]. 中华儿科杂志, 2022, 60(11): 1118-1126.
											 											 | 
										
																													
																						| [3] | 
																						 
											  Summar M L, Koelker S, Freedenberg D, et al.  The incidence of urea cycle disorders[J]. Mol Genet Metab, 2013, 110(1-2): 179-180. 
											 												 
																									doi: 10.1016/j.ymgme.2013.07.008
																																					pmid: 23972786
																							 											 | 
										
																													
																						| [4] | 
																						 
											  孔元原, 韩连书, 杨艳玲, 等. 鸟氨酸氨甲酰转移酶缺乏症诊治专家共识[J]. 浙江大学学报(医学版), 2020, 49(5): 539-547.
											 											 | 
										
																													
																						| [5] | 
																						 
											  曾健生. 高氨血症相关遗传代谢病危重症[J]. 中国实用儿科杂志, 2015, 30(8): 573-578.
											 											 | 
										
																													
																						| [6] | 
																						 
											  Batshaw M L. Hyperammonemia[J]. Curr Probl Pediatr, 1984, 14(11): 1-69. 
											 												 
																																					pmid: 6510017
																							 											 | 
										
																													
																						| [7] | 
																						 
											  Auron A, Brophy PD. Hyperammonemia in review: pathophysiology, diagnosis, and treatment[J]. Pediatr Nephrol, 2012, 27(2): 207-222. 
											 												 
																									doi: 10.1007/s00467-011-1838-5
																																					pmid: 21431427
																							 											 | 
										
																													
																						| [8] | 
																						 
											  Ogier De Baulny H, Schiff M, Dionisi-Vici C. Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a classic urea cycle disorder[J]. Mol Genet Metab, 2012, 106(1): 12-17. 
											 												 
																									doi: 10.1016/j.ymgme.2012.02.010
																																					pmid: 22402328
																							 											 | 
										
																													
																						| [9] | 
																						 
											  Palladino AA, Stanley CA. The hyperinsulinism/hyperammonemia syndrome[J]. Rev Endocr Metab Disord, 2010, 11(3): 171-178. 
											 												 
																									doi: 10.1007/s11154-010-9146-0
																																			 											 | 
										
																													
																						| [10] | 
																						 
											  Haberle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders[J]. Arch Biochem Biophys, 2013, 536(2): 101-108. 
											 												 
																									doi: 10.1016/j.abb.2013.04.009
																																					pmid: 23628343
																							 											 | 
										
																													
																						| [11] | 
																						 
											  Savy N, Brossier D, Brunel-Guitton C, et al.  Acute pediatric hyperammonemia: current diagnosis and management strategies[J]. Hepat Med, 2018, 10: 105-115.
											 											 | 
										
																													
																						| [12] | 
																						 
											  Gaertner F, Ahmad Z, Rosenberger G, et al.  Migra-tingplatelets are mechano-scavengers that collect and-bundlebacteria[J]. Cell, 2017, 171(6): 1368-1382. 
											 												 
																									doi: S0092-8674(17)31310-7
																																					pmid: 29195076
																							 											 | 
										
																													
																						| [13] | 
																						 
											  Gordon N. Ornithine transcarbamylase deficiency: a urea cycle defect[J]. Eur J Paediatr Neurol, 2003, 7(3): 115-121. 
											 												 
																									doi: 10.1016/S1090-3798(03)00040-0
																																			 											 | 
										
																													
																						| [14] | 
																						 
											  Summar ML, Mew NA. Inborn errors of metabolism with hyperammonemia: urea cycle defects and related disorders[J]. Pediatr Clin North Am, 2018, 65(2): 231-246. 
											 												 
																									doi: 10.1016/j.pcl.2017.11.004
																																			 											 | 
										
																													
																						| [15] | 
																						 
											  张尧, 杨艳玲. 重视高氨血症的早期诊断与精准干预[J]. 重庆医科大学学报, 2022, 47(3): 285-289.
											 											 | 
										
																													
																						| [16] | 
																						 
											  Ni B, Qin M, Zhao J, et al.  A glance at transient hyperammonemia of the newborn: pathophysiology, diag-nosis, and treatment: a review[J]. Medicine (Baltimore), 2022, 101(48): e31796. 
											 												 
																									doi: 10.1097/MD.0000000000031796
																																			 											 | 
										
																													
																						| [17] | 
																						 
											  邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版, 北京: 人民卫生出版社, 2011.
											 											 | 
										
																													
																						| [18] | 
																						 
											  陈哲晖, 董慧, 黄新文, 等. 尿素循环障碍的三级防控专家共识[J]. 中国实用儿科杂志, 2021, 36(10): 725-30.
											 											 | 
										
																													
																						| [19] | 
																						 
											  Lichter-Konecki U, Nadkarni V, Moudgil A, et al.  Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias[J]. Mol Genet Metab, 2013, 109(4): 354-359. 
											 												 
																									doi: 10.1016/j.ymgme.2013.05.014
																																					pmid: 23791307
																							 											 | 
										
																													
																						| [20] | 
																						 
											  Daniotti M, La Marca G, Fiorini P, et al.  New developments in the treatment of hyperammonemia: emerging use of carglumic acid[J]. Int J Gen Med, 2011, 4: 21-28. 
											 												 
																									doi: 10.2147/IJGM.S10490
																																					pmid: 21403788
																							 											 | 
										
																													
																						| [21] | 
																						 
											  Kido J, Nakamura K, Mitsubuchi H, et al.  Long-term outcome and intervention of urea cycle disorders in Japan[J]. J Inherit Metab Dis, 2012, 35(5): 777-785. 
											 												 
																									doi: 10.1007/s10545-011-9427-0
																																					pmid: 22167275
																							 											 |